Cargando…

Decomposing the effect of drug benefit program on antihypertensive medication adherence among the elderly in urban China

PURPOSE: Hypertension is a rapidly growing epidemic in People’s Republic of China, yet it remains inadequately controlled. This study aimed to identify the relative contributions of program effects and patients’ characteristics to the differences in antihypertensive medication nonadherence between d...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Xiaochen, Zhang, Yuji, Zhang, Mei, Li, Xiaoju, Yin, Hongpo, Li, Ke, Jing, Mingxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628968/
https://www.ncbi.nlm.nih.gov/pubmed/31371928
http://dx.doi.org/10.2147/PPA.S201707
_version_ 1783435037292625920
author Ma, Xiaochen
Zhang, Yuji
Zhang, Mei
Li, Xiaoju
Yin, Hongpo
Li, Ke
Jing, Mingxia
author_facet Ma, Xiaochen
Zhang, Yuji
Zhang, Mei
Li, Xiaoju
Yin, Hongpo
Li, Ke
Jing, Mingxia
author_sort Ma, Xiaochen
collection PubMed
description PURPOSE: Hypertension is a rapidly growing epidemic in People’s Republic of China, yet it remains inadequately controlled. This study aimed to identify the relative contributions of program effects and patients’ characteristics to the differences in antihypertensive medication nonadherence between drug benefit program enrollees and non-enrollees. PATIENTS AND METHODS: Data were from a cross-sectional survey of 1,969 community-dwelling elderly adults with hypertension. Self-reported adherence was measured following previous studies in People’s Republic of China. The Blinder-Oaxaca nonlinear decomposition method was used to identify the relative contributions of program effects and patients’ individual characteristics. RESULTS: Eleven percent of the drug benefit program enrollees were nonadherent to their medication, while 17% of non-enrollees were. Blinder-Oaxaca decomposition identified that over 60% of the gap between the two groups was due to the program effects (P=0.024). The rest could be explained by differences in observable characteristics (P<0.001), such as diabetic status, duration of hypertension, and blood pressure control. CONCLUSION: The study confirmed that drug benefit program enrollees were more likely to be adherent to their antihypertensive medication than non-enrollees in the context of People’s Republic of China.
format Online
Article
Text
id pubmed-6628968
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-66289682019-08-01 Decomposing the effect of drug benefit program on antihypertensive medication adherence among the elderly in urban China Ma, Xiaochen Zhang, Yuji Zhang, Mei Li, Xiaoju Yin, Hongpo Li, Ke Jing, Mingxia Patient Prefer Adherence Original Research PURPOSE: Hypertension is a rapidly growing epidemic in People’s Republic of China, yet it remains inadequately controlled. This study aimed to identify the relative contributions of program effects and patients’ characteristics to the differences in antihypertensive medication nonadherence between drug benefit program enrollees and non-enrollees. PATIENTS AND METHODS: Data were from a cross-sectional survey of 1,969 community-dwelling elderly adults with hypertension. Self-reported adherence was measured following previous studies in People’s Republic of China. The Blinder-Oaxaca nonlinear decomposition method was used to identify the relative contributions of program effects and patients’ individual characteristics. RESULTS: Eleven percent of the drug benefit program enrollees were nonadherent to their medication, while 17% of non-enrollees were. Blinder-Oaxaca decomposition identified that over 60% of the gap between the two groups was due to the program effects (P=0.024). The rest could be explained by differences in observable characteristics (P<0.001), such as diabetic status, duration of hypertension, and blood pressure control. CONCLUSION: The study confirmed that drug benefit program enrollees were more likely to be adherent to their antihypertensive medication than non-enrollees in the context of People’s Republic of China. Dove 2019-07-11 /pmc/articles/PMC6628968/ /pubmed/31371928 http://dx.doi.org/10.2147/PPA.S201707 Text en © 2019 Ma et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Ma, Xiaochen
Zhang, Yuji
Zhang, Mei
Li, Xiaoju
Yin, Hongpo
Li, Ke
Jing, Mingxia
Decomposing the effect of drug benefit program on antihypertensive medication adherence among the elderly in urban China
title Decomposing the effect of drug benefit program on antihypertensive medication adherence among the elderly in urban China
title_full Decomposing the effect of drug benefit program on antihypertensive medication adherence among the elderly in urban China
title_fullStr Decomposing the effect of drug benefit program on antihypertensive medication adherence among the elderly in urban China
title_full_unstemmed Decomposing the effect of drug benefit program on antihypertensive medication adherence among the elderly in urban China
title_short Decomposing the effect of drug benefit program on antihypertensive medication adherence among the elderly in urban China
title_sort decomposing the effect of drug benefit program on antihypertensive medication adherence among the elderly in urban china
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628968/
https://www.ncbi.nlm.nih.gov/pubmed/31371928
http://dx.doi.org/10.2147/PPA.S201707
work_keys_str_mv AT maxiaochen decomposingtheeffectofdrugbenefitprogramonantihypertensivemedicationadherenceamongtheelderlyinurbanchina
AT zhangyuji decomposingtheeffectofdrugbenefitprogramonantihypertensivemedicationadherenceamongtheelderlyinurbanchina
AT zhangmei decomposingtheeffectofdrugbenefitprogramonantihypertensivemedicationadherenceamongtheelderlyinurbanchina
AT lixiaoju decomposingtheeffectofdrugbenefitprogramonantihypertensivemedicationadherenceamongtheelderlyinurbanchina
AT yinhongpo decomposingtheeffectofdrugbenefitprogramonantihypertensivemedicationadherenceamongtheelderlyinurbanchina
AT like decomposingtheeffectofdrugbenefitprogramonantihypertensivemedicationadherenceamongtheelderlyinurbanchina
AT jingmingxia decomposingtheeffectofdrugbenefitprogramonantihypertensivemedicationadherenceamongtheelderlyinurbanchina